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ABSTRACT 
Memory impairment is one of the most common adverse following epilepsy, particularly complex 
partial epilepsy. Cytokines physiologically play an important role in memory impairment by preventing long 
term potentiation process in hypocampus. Several literatures have mentioned that IL-1, IL-6 and 
antagonist receptor IL-1Ra are crucial cytokines in complex partial epilepsy. This study aims to find out 
whether high level of IL-1 and IL-6 as well as low level of IL-1Ra might be risk factors of memory 
impairment in complex partial epilepsy patient. 
 This was a case control study, enrolling 30 complex partial epilepsy patients with memory 
impairment as case group and 30 complex partial epilepsy patients without memory impairment as control 
group. 
          In this study, it was obtained that the mean of IL-1β level in case group was significantly higher 
compared to the control (2.74 ± 4.36 vs. 0.42 ± 0.18 pg/ml, p = 0.007). The mean of IL-6 in case group was 
significantly higher compare to control (5.89 ± 6.32 vs. 2.34 ± 1.80 pg/ml, p = 0.006). The mean of IL-1Ra 
level of the case group was not significantly higher compared to the control (519.81 ± 262.64 vs. 413.28 ± 
106.85, p = 0.767). By applying bivariate analysis, McNemar’s test, we observed that IL-1β with cut off point 
0.63 pg/ml and OR = 70 is a risk factor of memory impairment in complex partial epilepsy indicated by p = 
0.001. Similar result was also gained for IL-6 with cut off point 2.87 pg/ml and OR = 4.57 as a risk factor of 
memory impairment in complex partial epilepsy indicated by p = 0.007. Meanwhile, IL- 1Ra with cut off 
point 471 pg/ml and OR = 0.727 was not as a risk factor of memory impairment in complex partial epilepsy 
indicated by p = 0.573. 
         It can be concluded that the high level of IL-1B and IL-6 were the risk factors of memory impairment in 
complex partial epilepsy patients. High level 1L-1B patient was 70 times higher risk of becoming memory 
impaired. High IL-6 patients will have the risk nearly 5 times higher. The low level of IL-1Ra does not as a 
risk factor in epilepsy patients for having the following memory impairment.  
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INTRODUCTION 
Epilepsy is a condition of unprovoked recurrent 
epileptic seizures at least 24 hours apart. Epileptic 
seizure manifests abnormal electrical discharge brain 
dysfunction. Prevalence of epilepsy based on 
epidemiology study was in the range of 0.5% - 2%.  
Assuming that Indonesian population is 250.000.000 
hence the number of people with epilepsy will reach 
1.250.000 – 5.000.000.
1 
 
Correspondence: Purwa-Samatra, D. P. G 
Department of Neurology Faculty Medicine  
Udayana University, Bali-Indonesia 
Email: purwa_bali@yahoo.com 
Epilepsy causes brain dysfuction which in turn 
emerge some following neurological ailments such as 
mental disorders and social problems. Individuals with 
epilepsy will deal with work place, litigation, 
education, career and marriage issues as  following 
social problems of their illness. 
The effect on intellectual development of 
epilepsy  in majority would be living with cognitive 
function and behaviour problems. Furthermore, 
epilepsy patients will live with social stigma attached  
to being abnormally low intelligence. A study of 30 
generalized and 14 partial epilepsy patients which are 
on antiepilepsy drugs  (AED) had been conducted by 
Sidiarto, Neurology Departement of FK UI/RS CM. This 
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study concluded that  75% of epilepsy patients have 
retrieval memory impairment and AEDs do not 
interfere with memory impairment. The National Child 
Development Study, United Kingdom in 1985 
mentioned that impaired memory as one of cognitive 
function has decreased  intellectual ability in 30 
patients with epilepsy and cognitive function began to 
gain more concern lately in  20 century. The advance 
in neuroscience particularly in molecular biology has 
drawn great attention of researchers to investigate on 
epilepsy which in turn  disclosed  the role of 
neurotransmitter in epilepsy. 
Glutamate has been known as excitatory 
neurotransmitter in pathophysiology of epilepsy, 
influx of  Ca ion will occur in the excited post synaptic 
neuron, result in depolarisation. If this processes 
overexcite the neuron, the seizure occurs. Beside 
Glutamate the other neurotransmitter is Gamma 
Amino Butiric Acid (GABA). GABA acts as an inhibitory 
neurotransmitter through Ion Cl
- 
channel induces by 
hyperpolarisation of the post synaptic membrane to 
complete inhibition process.
2,3 
Despite its role in the pathophysiology of 
epilepsy, neurotransmitter has significant role in the 
memory and learning processes. Based on the model 
researches, memory process  (to recall) is formed by 
the synapse  activities through repetitive stimulation 
(exprience-dependent synaptic trnsmission). These 
result in phosphorilation of protein membrane and 
followed by Long Term Potentiation (LTP) in 
Hypocampus.
2,4
 
Individuals with epilepsy release an excessive 
amount of glutamate by which create neurotoxicity 
and damage to the neurons. The injured neurons 
release proinflammatory cytokine particularly IL-1, IL-6 
and TNF-α.
 
IL-1ß subset of IL -1 is a proconvulsive 
cytokine and it interfere with LTP by disrupting protein 
kinase activity and calcium-calmodulin dependent 
protein kinase II (Ca MK II). Disrupting this process will 
prevent the synapses potentiation and LTP process in 
creating memory. At first these affect the immidiate 
and short term memory and later  eventually affect 
longterm memory.
5,6
 In normal condition IL-1 and IL-
1Ra have an activity as an inhibitory and equally 
maintained. Decrease of IL-1Ra will be followed by 
decrease of inhibitory activity.
4,7,8 
During seizure glutamate is released excessively, 
since glutamate induce neurotoxicity, this will lead to 
neuronal and glial (astrocyte) injury followed by 
proinflammatroy cytokine release such as  large 
amount of IL-1ß and IL-6. This leads to increase of 
antagonist receptor IL-1Ra expression. In certain 
condition  when increase of IL-1ß and IL-6 did not 
followed by increase of antagonist receptor of IL-1Ra, 
the LTP proscess in hypocampus  will be disrupted as 
well as the formation of memory. Hence seizure 
cascade  result in memory impairment. In certain 
condition if the increase of  IL-1ß and IL-6 is not equall 
with increase of antagonist receptor of IL-1Ra, It will 
result in memory impairment. This study aims to find 
out whether increase of IL-1ß, IL-6 and decrease of IL-
1Ra will impair the memory of complex partial 
epilepsy individual.
 
 
PATIENTS AND METHOD 
The study design is match pair case control study, 
aimed to find out whether the increase of IL-1ß, IL-6 
and decrease of IL-1Ra are the risk factors of memory 
impairment in patient with partial complex epilepsy. 
Sample of the study were 60 complex partial 
epilepsy patients who fulfilled the inclusion and 
exclusion criterions. They were recruited from the 
reachable representative population in Neurology out 
patient clinic of Sanglah General Hospital and Private 
practice office for 14 months. They were selected as 
the sample after they agreed to participate in this 
study. They were asked for doing some tests such as 
story recall memory test and mini mental status test 
for the patients who had been suffering from epilepsy 
for over 6-8 months without an episode of seizure. 
The sample were classified into 2 groups: 30  
complex partial epilepsy patients with memory 
impairment as the case group, and 30 complex partial 
epilepsy patients without memory impairment as the 
control group. These groups were matched according 
to age, length of suffering epilepsy, type of AED and 
education. 
The level of IL-1ß, IL-6  and  IL-1Ra were 
measured in each group. Serum was taken from blood 
samples after they were left to clot in room 
temperature for about 30-45 minutes and 
centrifugation in 3000 RPM/15 minute. The level of IL-
1ß was examined by ELISA sandwich (pg/ml). The cut- 
off point for the highest IL-1ß was determined by 
using ROC curve since there has not been a confirmed 
standard level for IL-1 ß yet. The level above the cut-
off point was categorized as high and below the cut-
off point was categorized as low. According to ROC 
curve the cut-off point for IL-1ß is 0.63 pg/ml 
(sensitivity is of 93% and specificity is of 83%). 
Research material is 15 cc of blood samples which 
were taken from cubital vein. The samples were left in 
room temperature until they clotted (30-45 minutes) 
and to be centrifuged in 3000 RPM/15 minute. The 
blood serum was taken and kept in 9 cups. The cups 
were labeled, 3 of them for IL-1ß examination, 3 more 
for IL-6 examination, and the last 3 for IL-1Ra 
examination using ELISA sandwich method (pg/ml). 
Data obtained were statistically analyzed by 
comparative study. The normal dispersion data was 
tested by t-independent test, abnormal dispersion 
data was tested by Mann-Whitney U test. McNemar 
test was done to analyze the odd ratio of each non-
dependent variable. To analyze the odd ratio of all the 
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variables simultaneously, Logistic Regression test of 
Multivariate test was conducted. All statistic analyze 
was performed in SPSS for windows program. 
 
RESULTS 
Base line data were listed in Table 1. As can be 
seen in Table 1 age, length of suffering epilepsy and 
education were normally distributed (p>0.05). 
 
Table 1 Base line Data of Subject 
 
Characteristic 
Groups 
t p 
Case Control 
Age (years) 23.43±8.18 21.93±7.44 0.743 0.460 
Length of 
epilepsy 
(month) 
7.00±0.91 7.07±0.94 0.278 0.782 
IL-1 (pg/mL) 2.74±4.36 0.42±0.18 2.91 0.007 
IL-6 (pg/mL) 5.89±6.32 2.34±1.80 2.96 0.006 
IL-1Ra 
(pg/mL) 
440.85±154.9 413.28±106.8 430 0.767 
 
The level of IL-1ß, IL-6 are significantly different 
between case and control group (p<0.05), and no 
significant difference between case and control in the 
level of IL-Ra (p>0.05). 
 
Chi-square test was applied to analyze the 
significance of increased IL-1ß, IL-6, and IL-1Ra as the 
risk factors of memory impairment, as seen in Table 2. 
The cut-off point level of IL-1ß is 0.63 according to the 
ROC curve (sensitivity of 93% and specificity of 83%), 
and categorized as high level if the level is ≥ 0.63. 
 
Table 2  The risk of high level of IL-6  to the incidence 
of memory impairment 
Parameter 
Groups 
OR CI  95% p* 
case control 
IL-1β High 
Low 
25 
5 
2 
28 
70 12.46- 
393.36 
0.001 
IL-6 High 
Low 
16 
14 
6 
24 
4.57 1.45-
14.39 
0.007 
IL-1Ra High 
Low 
20 
10 
22 
28 
0.73 0.24-
2.21 
0.573 
*significance at p < 0.05 
 
Table 2 shows that the increase of IL-1ß ≥ 0.63 (high 
IL-1ß) might be able to increase the incidence of 
memory impairment 70 times higher in partial 
complex epilepsy patient (OR = 70; CI 95%: 12.46 – 
393.36); p = 0.001). 
The cut-off point level of IL-6 is 2.87 according to 
the ROC curve (sensitivity of 80% and specificity of 
53%), and categorized as high level if the level is ≥ 
2.87. The risk of high level of IL-6 to the incidence of 
memory impairment 
Table 2 shows that the increased level of IL-6 ≥ 
2.87 (high IL-6) might be able to increase the incidence 
of memory impairment in complex partial epilepsy 
patient 5 time higher (OR=4.57; CI 95%: 1.45-14.39; p 
= 0.007) 
The risk of low IL-1Ra level to the incidence of 
memory impairment was analyzed by applying Chi-
square test. The result shows in Table 2, IL-1Ra cut-off 
point is 471.00 (sensitivity of 73% and spesifisity of 
63%) applied according to the ROC curve. Low level of 
IL-1Ra is  471.00. Table 2 shows that IL-1Ra ≤ 471.00 
(low IL-1Ra) does not increase the risk of incidence of 
memory impairment in complex partial epilepsy 
patient with OR is  0.73 s higher ( RO= 0.727; CI 95% : 
0.24-2.21;0.573). 
Bivariate analysis revealed two variables which 
are IL-1ß and IL-6, significantly related to the incidence 
of memory impairment in partial complex epilepsy. 
Furthemore these two variables were analysed in 
depth to figure out which of them affect more to the 
memory impairment. The analyses was conducted as 
follow : risk variables are ; X1 = IL-1ß, and X2 = IL-6. 
The analysis was performed simultaneously using 
logictic regression of multivariate analysis, the  
Backward Wald method, a selection method  of 
dependent and independent variables of memory 
impairment. The result is shown in Table 3. 
 
Table 3 Multivariate  analysis 
Risk  
factor 
OR 
CI  95 % 
p 
Low  limit Upper  limit 
IL-1β 63.86 10.24 398.40 0.001 
IL-6 1.28 0.21 7.91 0.791 
 
Table 3 reveals that only one variable is significant to 
increase the incidence of memory impairment. This 
risk factor is IL-1ß (OR = 63.86: CI 95%: 10.24 – 398.40, 
p = 0.001). The multivariate analysis revealed that in 
causing memory impairment among partial complex 
epilepsy patient, IL-1ß is more important than IL-6 . 
 
DISCUSSION 
Mean of IL-1ß level between case and control 
groups were different significantly (case 2.74 ± 4.36 
pg/ml, control 0.42 ± 0.18 pg/ml, p = 0.007), with 
McNemar test OR is 70 (CI 95%: 12.46 – 3393.46, p = 
0.001). The meaning of this result is that of increased 
IL-1ß level is the risk factor of memory impairment in 
partial complex epilepsy and individuals with high 
level of IL-1ß have the risk to become memory 
impaired 70 times higher compared with  low level of 
IL-1ß  individuals. The research result supports the 
theory of high level of IL-1ß will impair the memory 
prosessing. Other investigator, Bruno Conti (2008) in 
his immunohistochemistry study on mice showed that 
there was 50 – 100 fold increase of IL-1ß level in first  
90 minutes of seizure and kept maintained at this level 
for a long time.
9
   An animal study by Annamaria & 
Baram (2007), obtain similar result that IL-1ß played 
significant role  in creating  cognitive disfunction in 
provoked seizure animals.
7,10-12
 High level of IL-1ß is 
obtained as the risk factor of memory impairment, 
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hence the result of this study might be able to be 
applied on epilepsy patient to prevent and detect 
earlier the possibility of following memory 
impairment, by examining the level of IL-1ß in partial 
complex epilepsy patients serum. 
This study shows that mean of IL-6 level between 
case and control  was significantly different (case 5.89 
± 6.32 pg/ml, control 2.34 ± 1.80 pg/ml, p = 0.006). 
McNemar test revealed OR = 4.57 (CI 955: 1.45 – 
14.39; p = 0.007). This result indicates that high level 
of  IL-6 is the risk factor for memory impairment in 
complex partial epilepsy patient. This will increase the 
risk  nearly 5 fold compared with the low level of IL-6. 
The result also supports the theory that high level of 
IL-6 will impair the memory process. Giovanna et al 
(2000), according to his study on mice, said  t IL-6 
provoked seizure in previously healthy mice. In 
accordance with this result, examining the level of IL-6 
might be used as a marker to detect and prevent 
memory impairment.
13 
The level of IL-1Ra in partial complex epilepsy 
patients with memory impairment were higher 
compared with without memory impairment ( case 
519.81 ± 262.64 pg/ml, control 413.28 ± 106.85 pg/ml, 
p = 0.125)but the result was not statistically significant 
with p = 0.05. The result indicated that Low level of IL-
1Ra is not the risk factor of memory impairment and 
failed to support the theory. The reason of this might 
be because the samples of research were not in 
seizure when their blood sample  were taken. In non 
seizure state, the expression of IL-1Ra can not be used 
as the marker. IL-1ß and IL-6 remained high during 
non seizure state because the degenerative process 
was not ceased. 
 
CONCLUSION 
High level of IL-1ß and IL-6 were determined as 
risk factors of memory impairment in complex partial 
epilepsy patients, high level of IL-1ß increase the risk 
to 70 times higher. Complex partial epilepsy patients 
with high level of IL-6 increase the risk to impair 
memory nearly 5 fold higher. Low level of IL-1Ra in 
epilepsy patient does not risk the patient to have 
memory imparment. 
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